Servier Invites to Explore Precision Medicine and Real-World Evidence in Cholangiocarcinoma at ESMO GI 2026
servier.com

Servier Invites to Explore Precision Medicine and Real-World Evidence in Cholangiocarcinoma at ESMO GI 2026

Servier Pharmaceuticals shared a post on X:

“Attending ESMO GI 2026? We’re looking forward to seeing you at our symposium, “Impact in Practice: How Precision Medicine and Real-World Evidence are Shaping Cholangiocarcinoma Care

Today at 6:15 pm (CEST) and join us at our booth – N° 2

Learn more about our commitment to oncology here.”

Servier

Other articles about ESMO GI 2026 on OncoDaily.